North America Radiopharmaceuticals Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Radiopharmaceuticals Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Radiopharmaceuticals Market Regional Analysis

6.2 North America Radiopharmaceuticals Market Revenue 2019-2028 (US$ Million)

6.3 North America Radiopharmaceuticals Market Forecast Analysis

7. North America Radiopharmaceuticals Market Analysis – by Type

7.1 Diagnostic Nuclear Medicine

7.1.1 Overview
7.1.2 Diagnostic Nuclear Medicine: North America Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Therapeutic Nuclear Medicine

7.2.1 Overview
7.2.2 Therapeutic Nuclear Medicine: North America Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Radiopharmaceuticals Market Analysis – by Application

8.1 Oncology

8.1.1 Overview
8.1.2 Oncology: North America Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Cardiology

8.2.1 Overview
8.2.2 Cardiology: North America Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Neurology

8.3.1 Overview
8.3.2 Neurology: North America Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Radiopharmaceuticals Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: North America Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Imaging Centers

9.2.1 Overview
9.2.2 Imaging Centers: North America Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Academic and Research Centers

9.3.1 Overview
9.3.2 Academic and Research Centers: North America Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Radiopharmaceuticals Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Radiopharmaceuticals Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Radiopharmaceuticals Market Breakdown, by Type
10.2.1.1.2 US: North America Radiopharmaceuticals Market Breakdown, by Application
10.2.1.1.3 US: North America Radiopharmaceuticals Market Breakdown, by End User

10.2.1.2 Canada: North America Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Radiopharmaceuticals Market Breakdown, by Type
10.2.1.2.2 Canada: North America Radiopharmaceuticals Market Breakdown, by Application
10.2.1.2.3 Canada: North America Radiopharmaceuticals Market Breakdown, by End User

10.2.1.3 Mexico : North America Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Radiopharmaceuticals Market Breakdown, by Type
10.2.1.3.2 Mexico : North America Radiopharmaceuticals Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Radiopharmaceuticals Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Advanced Accelerator Applications

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bayer AG

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bracco Imaging S.p.A

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Cardinal Health Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Curium

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 ECZACIBAI MONROL NUCLEAR PRODUCTS CO.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 GENERAL ELECTRIC

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Lantheus Medical Imaging, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Nordion

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 NTP RADIOISOTOPES

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Radiopharmaceuticals Market

Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)